Tetrous
Sherman Oaks, US · Founded 2019 · Delaware corporation
Tetrous is a regenerative medicine company developing demineralized bone fiber (DBF) EnFix implants that support biologic healing at the bone-to-tendon junction (enthesis) following sports medicine surgery. Its products are used by orthopedic surgeons across procedures such as rotator cuff, Achilles, gluteus medius, biceps, and lateral epicondylar repairs.
Founders & leadership
Tetrous was founded in 2019 by Andrew J. Carter.
AJ
Andrew J. CarterCo-founder, Chief Technology Officer, and Director
BE
Bradley E. PattinCo-founder, CEO, and Chairman of the Board
FP
Frank PhillipsNamed on SEC filing
Board
GA
Gunnar AnderssonBoard director
NV
Nikhil VermaBoard director
MM
Matthew MuscioBoard director
FP
Frank PhilipsBoard director
JB
John BojanowskiChief Commercial Officer and Director
SB
Simon BerryBoard director
JI
Jan IwanczykBoard director
Funding
SEC filings, press & company announcements$2.2M disclosed across 2 of 3 rounds · 2023–2026
- Undisclosed amountSeries AMar 2025Source ↗
▶$1.7MraisedApr 2026 · 64 investors · BiotechnologyRule 506(b)
▶$1.7MraisedApr 2026 · 64 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Gunnar AnderssonDirector
- Nikhil VermaDirector
- Matthew MuscioDirector
- Andy CarterDirector
- Frank PhilipsDirector
- John BojanowskiDirector
- Simon BerryDirector
- Jan IwanczykDirector
- Bradley E. PattExecutive Officer, Director
- Offering amount
- $4M
- Amount sold
- $1.7M
- First sale
- Apr 2026
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$444.6KraisedDec 2023 · 2 investors · BiotechnologyRule 506(c)
▶$444.6KraisedDec 2023 · 2 investors · Biotechnology
Rule 506(c)Officers, directors & promoters on the filing
- Nikhil VermaDirector
- Jan IwanczykDirector
- John BojanowskiDirector
- Frank PhillipsDirector
- Gunnar AnderssonDirector
- Bradley E. PattExecutive Officer, Director
- Andy CarterDirector
- Simon BerryDirector
- Offering amount
- $5M
- Amount sold
- $444.6K
- Minimum investment
- $50K
- Placement agents
- Sutter Securities Group
- First sale
- Dec 2023
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06c
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 3
by search overlap
Globus Medical8 shared keywordsGlobus Medical designs and manufactures spine, trauma, and robotic surgical products for the orthopedic medical device market. The company serves hospitals and surgical centers globally.
OsteoCentric6 shared keywordsOsteocentric develops orthopedic implant systems for bone fixation, including fasteners, plates, and surgical instruments that use UnifiMI mechanical integration technology. The company serves orthopedic surgeons and hospitals treating fractures and skeletal injuries.
Read the Press Release6 shared keywordsStryker is a medical technology company that develops and manufactures products across areas such as orthopaedics, surgical equipment, neurotechnology, and spine care for hospitals and healthcare providers. It operates globally across the Americas, Europe, Asia-Pacific, and the Middle East.
Companies competing with Tetrous for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Tetrous do?
- Tetrous is a regenerative medicine company developing demineralized bone fiber (DBF) EnFix implants that support biologic healing at the bone-to-tendon junction (enthesis) following sports medicine surgery. Its products are used by orthopedic surgeons across procedures such as rotator cuff, Achilles, gluteus medius, biceps, and lateral epicondylar repairs.
- Who founded Tetrous?
- Tetrous was founded by Andrew J. Carter in 2019.
- How much funding has Tetrous raised?
- Tetrous has disclosed $2.2M raised across 2 of its 3 known rounds.
- Where is Tetrous headquartered?
- Tetrous is headquartered in Sherman Oaks, US.